DeviceClearance

K002609

Substantially Equivalent

TINA-QUANT RHEUMATOID FACTORS II TEST SYSTEM

Applicant
Roche Diagnostics Corp.
Product code
DHR
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Indianapolis, IN, US
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.